XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
DGX Quest Diagnostics
- 168.770
- +0.050+0.03%
Close Feb 14 16:00 ET
- 168.770
- 0.0000.00%
Post 20:01 ET
18.84BMarket Cap22.68P/E (TTM)
171.300High168.110Low1.33MVolume169.250Open168.720Pre Close224.97MTurnover1.20%Turnover Ratio21.95P/E (Static)111.62MShares171.30052wk High2.76P/B18.65BFloat Cap120.74952wk Low2.96Dividend TTM110.50MShs Float171.300Historical High1.75%Div YieldTTM1.89%Amplitude2.570Historical Low169.512Avg Price1Lot Size
Quest Diagnostics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.70%9.87B | 14.55%2.62B | 8.41%2.49B | 2.52%2.4B | 1.50%2.37B | -6.38%9.25B | -1.93%2.29B | -7.68%2.3B | -4.69%2.34B | -10.72%2.33B |
| Operating revenue | 6.70%9.87B | 14.55%2.62B | 8.41%2.49B | 2.52%2.4B | 1.50%2.37B | -6.38%9.25B | -1.93%2.29B | -7.68%2.3B | -4.69%2.34B | -10.72%2.33B |
| Cost of revenue | 6.92%6.63B | 13.60%1.76B | 8.83%1.68B | 3.04%1.59B | 2.24%1.6B | -3.89%6.2B | -1.46%1.55B | -4.76%1.54B | -4.03%1.55B | -5.22%1.56B |
| Gross profit | 6.26%3.24B | 16.58%858M | 7.56%811M | 1.52%804M | 0.00%771M | -11.07%3.05B | -2.90%736M | -13.13%754M | -5.94%792M | -20.10%771M |
| Operating expense | 5.97%1.9B | 5.97%497M | 16.75%481M | 1.13%449M | 1.07%471M | -10.67%1.79B | -24.72%469M | -13.45%412M | -2.20%444M | 3.10%466M |
| Selling and administrative expenses | 7.80%1.77B | 14.50%466M | 17.89%448M | 0.00%416M | 0.23%440M | -12.38%1.64B | -27.71%407M | -18.10%380M | -1.42%416M | 3.29%439M |
| Depreciation amortization depletion | 17.59%127M | 37.04%37M | 18.52%32M | 3.57%29M | 11.54%29M | -10.00%108M | -30.77%27M | 0.00%27M | 3.70%28M | -3.70%26M |
| -Depreciation and amortization | 17.59%127M | 37.04%37M | 18.52%32M | 3.57%29M | 11.54%29M | -10.00%108M | -30.77%27M | 0.00%27M | 3.70%28M | -3.70%26M |
| Other operating expenses | -97.56%1M | -117.14%-6M | -80.00%1M | --4M | 100.00%2M | 272.73%41M | 66.67%35M | 133.33%5M | ---- | --1M |
| Operating profit | 6.66%1.35B | 35.21%361M | -3.51%330M | 2.01%355M | -1.64%300M | -11.62%1.26B | 97.78%267M | -12.76%342M | -10.31%348M | -40.55%305M |
| Net non-operating interest income expense | -32.24%-201M | -62.50%-65M | -22.50%-49M | -18.92%-44M | -22.86%-43M | -10.14%-152M | -25.00%-40M | -21.21%-40M | -2.78%-37M | 5.41%-35M |
| Non-operating interest income | ---- | ---- | 800.00%9M | 50.00%3M | 200.00%6M | 10.00%11M | 50.00%6M | -75.00%1M | 0.00%2M | --2M |
| Non-operating interest expense | 23.31%201M | 41.30%65M | 41.46%58M | 20.51%47M | 32.43%49M | 10.14%163M | 27.78%46M | 10.81%41M | 2.63%39M | 0.00%37M |
| Other net income (expense) | 50.00%30M | -70.00%3M | 600.00%15M | -50.00%3M | 28.57%9M | 136.36%20M | 66.67%10M | 62.50%-3M | 120.69%6M | 129.17%7M |
| Other non- operating income (expenses) | 50.00%30M | -70.00%3M | 600.00%15M | -50.00%3M | 28.57%9M | 136.36%20M | 66.67%10M | 62.50%-3M | 120.69%6M | 129.17%7M |
| Income before tax | 3.98%1.18B | 26.16%299M | -1.00%296M | -0.95%314M | -3.97%266M | -8.50%1.13B | 117.43%237M | -14.81%299M | -1.86%317M | -38.72%277M |
| Income tax | 10.08%273M | 70.00%68M | -4.41%65M | -1.33%74M | 1.54%66M | -6.06%248M | 1,100.00%40M | -16.05%68M | -2.60%75M | -40.91%65M |
| Earnings from equity interest net of tax | -26.92%19M | -37.50%5M | 0.00%6M | --0 | 60.00%8M | -40.91%26M | 166.67%8M | 0.00%6M | 75.00%7M | -83.87%5M |
| Net income | 1.43%921M | 15.12%236M | 0.00%237M | -3.61%240M | -4.15%208M | -10.54%908M | 76.72%205M | -14.13%237M | -0.40%249M | -41.82%217M |
| Net income continuous Operations | 1.43%921M | 15.12%236M | 0.00%237M | -3.61%240M | -4.15%208M | -10.54%908M | 76.72%205M | -14.13%237M | -0.40%249M | -41.82%217M |
| Minority interest income | -7.41%50M | 7.69%14M | -8.33%11M | -21.43%11M | -6.67%14M | -21.74%54M | -13.33%13M | -40.00%12M | -12.50%14M | -16.67%15M |
| Net income attributable to the parent company | 1.99%871M | 15.63%222M | 0.44%226M | -2.55%229M | -3.96%194M | -9.73%854M | 90.10%192M | -12.11%225M | 0.43%235M | -43.10%202M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 25.00%5M | 2M | -50.00%1M | 0.00%1M | 0.00%1M | 0.00%4M | 0 | 0.00%2M | 0.00%1M | 0.00%1M |
| Net income attributable to common stockholders | 1.88%866M | 14.58%220M | 0.90%225M | -2.56%228M | -3.98%193M | -9.77%850M | 90.10%192M | -12.20%223M | 0.43%234M | -43.22%201M |
| Basic earnings per share | 2.50%7.78 | 15.12%1.98 | 1.01%2.01 | -1.44%2.05 | -3.33%1.74 | -6.30%7.59 | 93.26%1.72 | -9.55%1.99 | 4.00%2.08 | -39.39%1.8 |
| Diluted earnings per share | 2.67%7.69 | 14.71%1.95 | 1.53%1.99 | -0.98%2.03 | -3.37%1.72 | -6.02%7.49 | 95.40%1.7 | -9.68%1.96 | 4.59%2.05 | -39.04%1.78 |
| Dividend per share | 6.09%2.96 | 5.63%0.75 | 5.63%0.75 | 5.63%0.75 | 7.58%0.71 | 40.91%2.79 | 0.71 | 7.58%0.71 | 7.58%0.71 | 0.00%0.66 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call